-
Hebeisen, M., Schmidt, J., Guillaume, P., Baumgaertner, P., Speiser, D. E., Luescher, I. and Rufer, N. (2015). Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells. Cancer Res 75(10): 1983-1991.
-
Meyer, C., Cagnon, L., Costa-Nunes, C. M., Baumgaertner, P., Montandon, N., Leyvraz, L., Michielin, O., Romano, E. and Speiser, D. E. (2014). Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab. Cancer Immunol Immunother 63(3): 247-257.
-
Mahnke, Y. D., Devevre, E., Baumgaertner, P., Matter, M., Rufer, N., Romero, P. and Speiser, D. E. (2012). Human melanoma-specific CD8(+) T-cells from metastases are capable of antigen-specific degranulation and cytolysis directly ex vivo. Oncoimmunology 1(4): 467-530.
-
Lovgren, T., Baumgaertner, P., Wieckowski, S., Devevre, E., Guillaume, P., Luescher, I., Rufer, N. and Speiser, D. E. (2012). Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose. Cancer Immunol Immunother 61(6): 817-826.
-
Baumgaertner, P., Jandus, C., Rivals, J. P., Derre, L., Lovgren, T., Baitsch, L., Guillaume, P., Luescher, I. F., Berthod, G., Matter, M., Rufer, N., Michielin, O. and Speiser, D. E. (2012). Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells. Int J Cancer 130(11): 2607-2617.
-
Speiser, D. E., Wieckowski, S., Gupta, B., Iancu, E. M., Baumgaertner, P., Baitsch, L., Michielin, O., Romero, P. and Rufer, N. (2011). Single cell analysis reveals similar functional competence of dominant and nondominant CD8 T-cell clonotypes. Proc Natl Acad Sci U S A 108(37): 15318-15323.
-
Speiser, D. E., Baumgaertner, P., Voelter, V., Devevre, E., Barbey, C., Rufer, N. and Romero, P. (2008). Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen. Proc Natl Acad Sci U S A 105(10): 3849-3854.